T2 Biosystems, Inc.
TTOO · OTC
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $35,248 | $75,833 | $15,162 | $31,208 |
| - Cash | $2,083 | $4,246 | $6,208 | $15,689 |
| + Debt | $18,944 | $19,220 | $49,497 | $49,498 |
| Enterprise Value | $52,109 | $90,807 | $58,451 | $65,017 |
| Revenue | $1,985 | $1,952 | $2,061 | $1,679 |
| % Growth | 1.7% | -5.3% | 22.8% | – |
| Gross Profit | -$2,116 | -$741 | -$2,141 | -$969 |
| % Margin | -106.6% | -38% | -103.9% | -57.7% |
| EBITDA | -$9,688 | -$8,423 | -$12,291 | -$9,105 |
| % Margin | -488.1% | -431.5% | -596.4% | -542.3% |
| Net Income | -$10,117 | -$8,963 | -$13,534 | -$10,340 |
| % Margin | -509.7% | -459.2% | -656.7% | -615.8% |
| EPS Diluted | -0.57 | -0.64 | -2.66 | -2.08 |
| % Growth | 10.9% | 75.9% | -27.9% | – |
| Operating Cash Flow | -$6,252 | -$9,241 | -$11,683 | -$9,416 |
| Capital Expenditures | $0 | $0 | $0 | -$26 |
| Free Cash Flow | -$6,252 | -$9,241 | -$11,683 | -$9,442 |